Compounded Semaglutide and Compounded Tirzepatide are formulations of FDA-approved active ingredients, prepared by licensed compounding pharmacies under physician supervision
Lepore JJ, Olson E, Demopoulos L et al (2016) Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
A federal judicial panel has created a new multidistrict litigation (MDL) in Pennsylvania to centralize lawsuits alleging that GLP-1 weight-loss drugs caused vision loss, including NAION , placing the cases before Judge Karen Marston
Dietary supplements with metabolic support ingredients may provide modest benefit when combined with lifestyle changes, but effects are substantially smaller and highly individual
Studies show that long-term weekly use leads to better outcomes than short-term or inconsistent use